These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37581720)

  • 1. Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair.
    Kalkan A; Metze C; Iliadis C; Körber MI; Baldus S; Pfister R
    Clin Res Cardiol; 2024 Jan; 113(1):94-106. PubMed ID: 37581720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.
    Arnold SV; Li Z; Vemulapalli S; Baron SJ; Mack MJ; Kosinski AS; Reynolds MR; Hermiller JB; Rumsfeld JS; Cohen DJ
    JAMA Cardiol; 2018 Dec; 3(12):1151-1159. PubMed ID: 30476950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter mitral valve replacement or repair for secondary mitral regurgitation: a propensity score-matched analysis.
    Ludwig S; Kalbacher D; Ali WB; Weimann J; Adam M; Duncan A; Webb JG; Windecker S; Orban M; Giannini C; Coisne A; Karam N; Scotti A; Sondergaard L; Adamo M; Muller DWM; Butter C; Denti P; Melica B; Regazzoli D; Garatti A; Schmidt T; Andreas M; Dahle G; Taramasso M; Nickenig G; Dumonteil N; Walther T; Flagiello M; Kempfert J; Fam N; Ruge H; Rudolph TK; Wyler von Ballmoos MC; Metra M; Redwood S; Granada JF; Tang GHL; Latib A; Lurz P; von Bardeleben RS; Modine T; Hausleiter J; Conradi L;
    Eur J Heart Fail; 2023 Mar; 25(3):399-410. PubMed ID: 36883620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair.
    Metze C; Matzik AS; Scherner M; Körber MI; Michels G; Baldus S; Rudolph V; Pfister R
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1920-1929. PubMed ID: 28917516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison.
    Ludwig S; Conradi L; Cohen DJ; Coisne A; Scotti A; Abraham WT; Ben Ali W; Zhou Z; Li Y; Kar S; Duncan A; Lim DS; Adamo M; Redfors B; Muller DWM; Webb JG; Petronio AS; Ruge H; Nickenig G; Sondergaard L; Adam M; Regazzoli D; Garatti A; Schmidt T; Andreas M; Dahle G; Walther T; Kempfert J; Tang GHL; Redwood S; Taramasso M; Praz F; Fam N; Dumonteil N; Obadia JF; von Bardeleben RS; Rudolph TK; Reardon MJ; Metra M; Denti P; Mack MJ; Hausleiter J; Asch FM; Latib A; Lindenfeld J; Modine T; Stone GW; Granada JF;
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e013045. PubMed ID: 37194288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for long-term survival after transcatheter edge-to-edge mitral valve repair.
    Orban M; Orban M; Lesevic H; Braun D; Deseive S; Sonne C; Hutterer L; Grebmer C; Khandoga A; Pache J; Mehilli J; Schunkert H; Kastrati A; Hagl C; Bauer A; Massberg S; Boekstegers P; Nabauer M; Ott I; Hausleiter J
    J Interv Cardiol; 2017 Jun; 30(3):226-233. PubMed ID: 28370526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Commercial Introduction of Transcatheter Mitral Valve Repair on Mitral Surgical Practice.
    Niikura H; Gössl M; Bae R; Sun B; Askew J; Harris K; Mudy K; Strauss C; Stanberry L; Sweeney A; Sorajja P
    J Am Heart Assoc; 2020 Apr; 9(7):e014874. PubMed ID: 32248763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural changes in natriuretic peptide levels and clinical outcome after transcatheter mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Horn P; Sugiura A; Kelm M; Baldus S; Nickenig G; Westenfeld R; Pfister R; Becher MU
    ESC Heart Fail; 2021 Dec; 8(6):5237-5247. PubMed ID: 34519444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
    Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of effective regurgitant orifice area on outcome of secondary mitral regurgitation transcatheter repair.
    Karam N; Orban M; Kalbacher D; Butter C; Praz F; Lubos E; Bannehr M; Kassar M; Petrescu A; Iliadis C; Unterhuber M; Asselin A; Thiele H; Pfister R; Windecker S; Lurz P; von Bardeleben S; Hausleiter J;
    Clin Res Cardiol; 2021 May; 110(5):732-739. PubMed ID: 33661372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.
    Nickenig G; Estevez-Loureiro R; Franzen O; Tamburino C; Vanderheyden M; Lüscher TF; Moat N; Price S; Dall'Ara G; Winter R; Corti R; Grasso C; Snow TM; Jeger R; Blankenberg S; Settergren M; Tiroch K; Balzer J; Petronio AS; Büttner HJ; Ettori F; Sievert H; Fiorino MG; Claeys M; Ussia GP; Baumgartner H; Scandura S; Alamgir F; Keshavarzi F; Colombo A; Maisano F; Ebelt H; Aruta P; Lubos E; Plicht B; Schueler R; Pighi M; Di Mario C;
    J Am Coll Cardiol; 2014 Sep; 64(9):875-84. PubMed ID: 25169171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Arora S; Vemulapalli S; Stebbins A; Ramm CJ; Kosinski AS; Sorajja P; Piccini JP; Cavender MA; Vavalle JP
    JACC Cardiovasc Interv; 2019 Mar; 12(6):569-578. PubMed ID: 30898255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.
    Jogu HR; Arora S; Strassle PD; Patel C; Patil N; Venkatesh S; Alkhaimy H; Ramm CJ; Qamar A; Kim SM; Yeung M; Vavalle JP
    Catheter Cardiovasc Interv; 2020 May; 95(6):1195-1201. PubMed ID: 31478339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Lima FV; Kolte D; Rofeberg V; Molino J; Zhang Z; Elmariah S; Aronow HD; Abbott JD; Ben Assa E; Khera S; Gordon PC; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):664-674. PubMed ID: 31868999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair.
    Iliadis C; Metze C; Körber MI; Baldus S; Pfister R
    Int J Cardiol; 2020 Oct; 316():189-194. PubMed ID: 32470537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation.
    Benito-González T; Carrasco-Chinchilla F; Estévez-Loureiro R; Pascual I; Arzamendi D; Garrote-Coloma C; Nombela-Franco L; Pan M; Serrador A; Freixa X; Cid Alvarez AB; Hernández Antolín RA; Andraka L; Cruz-González I; López-Minguez JR; Díez Gil JL; Urbano-Carrillo C; Sanmiguel Cervera D; Sanchís J; Bosa F; Ruíz V; Molina E; Becerra-Muñoz VM; Gualis J; Avanzas P; Li CH; Baz JA; Jimenez-Quevedo P; Mesa D; Amat-Santos IJ; Regueiro A; Trillo R; Domínguez Franco AJ; Alonso-Briales JH; Fernández-Vázquez F
    Int J Cardiol; 2021 Dec; 345():29-35. PubMed ID: 34610357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.
    Muller DWM; Sorajja P; Duncan A; Bethea B; Dahle G; Grayburn P; Babaliaros V; Guerrero M; Thourani VH; Bedogni F; Denti P; Dumonteil N; Modine T; Jansz P; Chuang ML; Blanke P; Leipsic J; Badhwar V
    J Am Coll Cardiol; 2021 Nov; 78(19):1847-1859. PubMed ID: 34736561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.